Literature DB >> 33683650

A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).

Fanni Rencz1,2, Ariel Z Mitev3, Ákos Szabó1,4, Zsuzsanna Beretzky1,5, Adrienn K Poór6, Péter Holló6, Norbert Wikonkál6, Miklós Sárdy6, Sarolta Kárpáti6, Andrea Szegedi7,8, Éva Remenyik7, Valentin Brodszky9.   

Abstract

PURPOSE: Eight of the ten items of the Dermatology Life Quality Index (DLQI) have a 'not relevant' response (NRR) option. There are two possible ways to interpret NRRs: they may be considered 'not at all' or missing responses. We aim to compare the measurement performance of the DLQI in psoriasis patients when NRRs are scored as '0' (hereafter zero-scoring) and 'missing' (hereafter missing-scoring) using Rasch model analysis.
METHODS: Data of 425 patients with psoriasis from two earlier cross-sectional surveys were re-analysed. All patients completed the paper-based Hungarian version of the DLQI. A partial credit model was applied. The following model assumptions and measurement properties were tested: dimensionality, item fit, person reliability, order of response options and differential item functioning (DIF).
RESULTS: Principal component analysis of the residuals of the Rasch model confirmed the unidimensional structure of the DLQI. Person separation reliability indices were similar with zero-scoring (0.910) and missing-scoring (0.914) NRRs. With zero-scoring, items 6 (sport), 7 (working/studying) and 9 (sexual difficulties) suffered from item misfit and item-level disordering. With missing-scoring, no misfit was observed and only item 7 was illogically ordered. Six and three items showed DIF for gender and age, respectively, that were reduced to four and three by missing-scoring.
CONCLUSIONS: Missing-scoring NRRs resulted in an improved measurement performance of the scale. DLQI scores of patients with at least one vs. no NRRs cannot be directly compared. Our findings provide further empirical support to the DLQI-R scoring modification that treats NRRs as missing and replaces them with the average score of the relevant items.
© 2021. The Author(s).

Entities:  

Keywords:  DLQI-R; Dermatology Life Quality Index; Psoriasis; Psychometrics; Rasch model; ‘not relevant’ response

Year:  2021        PMID: 33683650     DOI: 10.1007/s11136-021-02803-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  29 in total

1.  Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines.

Authors:  F Rencz; V Brodszky; L Gulácsi; M Péntek; A K Poór; P Holló; A Szegedi; É Remenyik; M Sárdy; A Langenbruch; M A Radtke; M Gutknecht; M Augustin
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-03-19       Impact factor: 6.166

2.  Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.

Authors:  John S Barbieri; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

3.  Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.

Authors:  John S Barbieri; Daniel B Shin; Maha N Syed; Junko Takeshita; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2020-04-01       Impact factor: 10.282

4.  European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

Authors:  A Nast; P I Spuls; G van der Kraaij; P Gisondi; C Paul; A D Ormerod; P Saiag; C H Smith; E Dauden; E M de Jong; E Feist; R Jobling; M Maccarone; U Mrowietz; K A Papp; K Reich; S Rosumeck; T Talme; H B Thio; P van de Kerkhof; R N Werner; C Dressler
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-09-11       Impact factor: 6.166

5.  Dermatology Life Quality Index use in skin disease guidelines and registries worldwide.

Authors:  R K Singh; A Y Finlay
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-26       Impact factor: 6.166

6.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

7.  A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.

Authors:  F Rencz; A K Poór; M Péntek; P Holló; S Kárpáti; L Gulácsi; A Szegedi; É Remenyik; B Hidvégi; K Herszényi; H Jókai; Z Beretzky; V Brodszky
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-11-28       Impact factor: 6.166

8.  European S3-guidelines on the systemic treatment of psoriasis vulgaris.

Authors:  D Pathirana; A D Ormerod; P Saiag; C Smith; P I Spuls; A Nast; J Barker; J D Bos; G-R Burmester; S Chimenti; L Dubertret; B Eberlein; R Erdmann; J Ferguson; G Girolomoni; P Gisondi; A Giunta; C Griffiths; H Hönigsmann; M Hussain; R Jobling; S-L Karvonen; L Kemeny; I Kopp; C Leonardi; M Maccarone; A Menter; U Mrowietz; L Naldi; T Nijsten; J-P Ortonne; H-D Orzechowski; T Rantanen; K Reich; N Reytan; H Richards; H B Thio; P van de Kerkhof; B Rzany
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-10       Impact factor: 6.166

9.  Definition of treatment goals for moderate to severe psoriasis: a European consensus.

Authors:  U Mrowietz; K Kragballe; K Reich; P Spuls; C E M Griffiths; A Nast; J Franke; C Antoniou; P Arenberger; F Balieva; M Bylaite; O Correia; E Daudén; P Gisondi; L Iversen; L Kemény; M Lahfa; T Nijsten; T Rantanen; A Reich; T Rosenbach; S Segaert; C Smith; T Talme; B Volc-Platzer; N Yawalkar
Journal:  Arch Dermatol Res       Date:  2010-09-21       Impact factor: 3.017

10.  Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.

Authors:  Neuza da Silva; Matthias Augustin; Anna Langenbruch; Ulrich Mrowietz; Kristian Reich; Diamant Thaçi; Wolf-Henning Boehncke; Natalia Kirsten; Alexandra Danckworth; Rachel Sommer
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

View more
  1 in total

1.  Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients.

Authors:  Fanni Rencz; Ariel Z Mitev; Balázs Jenei; Valentin Brodszky
Journal:  Qual Life Res       Date:  2021-08-09       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.